Company Filing History:
Years Active: 2004-2007
Title: Jack E Lohman: Innovator in Cardiac Monitoring Technologies
Introduction
Jack E Lohman is a notable inventor based in Colgate, WI (US), recognized for his contributions to cardiac monitoring technologies. With a total of 3 patents, Lohman has developed innovative methods that enhance the detection and monitoring of cardiac arrhythmias, significantly impacting patient care.
Latest Patents
Lohman's latest patents include a "Method and apparatus for detecting a cardiac arrhythmia." This method involves acquiring baseline ECG samples that exhibit an arrhythmia to be detected, alongside a baseline arrhythmia-free ECG sample. The process includes manipulating each acquired baseline ECG sample to determine an equation that describes a reconstructed phase space related to the sample. Subsequently, an ECG sample to be tested is acquired, and a reconstructed phase space is mapped. The final step involves determining which of the equations most accurately describes the reconstructed phase space of the ECG sample being tested. Another significant patent is the "Long term cardiac monitor," which provides electrodes for daily ECG measurements without cumbersome connections. This monitor diagnoses ECG data to indicate the likelihood of an arrhythmia and can forward this information to healthcare professionals for review.
Career Highlights
Throughout his career, Lohman has been associated with companies such as Lohman Technologies, LLC and Lechnologies, LLC. His work has focused on developing technologies that improve the accuracy and convenience of cardiac monitoring.
Collaborations
Lohman has collaborated with notable individuals in his field, including Timothy L Lohman and Robert Baker. Their combined expertise has contributed to the advancement of cardiac monitoring technologies.
Conclusion
Jack E Lohman stands out as an innovator in the field of cardiac monitoring, with his patents reflecting a commitment to improving patient outcomes through technology. His work continues to influence the medical community and enhance the quality of care for patients experiencing cardiac arrhythmias.